Issue link: http://osercommunicationsgroup.uberflip.com/i/858130
Chain Drugstore Daily 2 3 Monday, August 21, 2017 UNIWEB: DYNAMIC INNOVATION FOR TODAY Let's consider the function of consulta- tion/immunization rooms, and how Uniweb can bring craftsmanship, func- tionality and beauty to your space. Why Uniweb? Uniweb provides rooms with: Convenience and Ease of Access With Uniweb's portable and flexible design, store designers can install the room virtually anywhere. Its ADA-com- pliant entries will accommodate all users of the space. The consult room can be placed near the check-out station for easy access for transactions, procedures or conversations between patients and phar- macy staff. Privacy and Comfort Uniweb crafts a welcoming ambiance with the use of privacy glass doors and panels to create a warm and inviting set- ting. Allowing for natural light keeps the room comfortable. Combine this with sound absorbing décor fabric panels to maintain patient confidentiality. Optimal Layouts Uniweb manufactures rooms based on your size and configuration specifica- tions which will fit into your current layout. Create an ADA-accessible alcove to allow seating for the pharma- cist, the patient and their caregiver or guardian. Premium Custom Décor and Finishes Many design possibilities are avail- able: custom metal finishes, trim strips, décor panels, laminates, wood and wood veneers, decorative metals, glass, tile, awnings, special lighting, signage and much more. Uniweb works with your staff and architects to design the room's exterior and interi- or to meet your company's specific aesthetic require- ments, including surface options, materials, colors and finishes to coordinate with your current store's interior. Together, they help to create a complimentary and inviting climate for customers and staff to enjoy. Support Equipment Uniweb FLEX Modular Counter Systems provide integrated and accom- modating clutter-free functional worksta- tions engineered and tailored to meet your specific needs. With adjustable height desks, optional Uniweb paneled shelving sides, an array of storage above and below the consult desk and infinite accessories, the area will keep your team organized and supplies conveniently within reach, allowing for maximum workflow. Does your fixture supplier do all this? You'd better double check! The ultimate beauty of Uniweb's craftsmanship: adaptable, portable and flexible. As your needs change, so can your consult room. Whether you need more space or need to change your oper- ation's layout, you are not locked into your original design. These dynamic rooms allow the freedom to design and equip your area for unsurpassed utility and appearance at an affordable price. Give Uniweb your challenges today. The company would be proud to show you current satisfied customer installa- tions, take you on a tour of the new, state- of-the-industry 180,000 square foot man- ufacturing facility and meet with your team to start discussions on your next remodel project. Visit Uniweb at booth #2631. For more information, call 800.486.4932 or go to www.uniwebinc.com. WEST-WARD PHARMACEUTICALS: SOLID FOUNDATION, BRIGHT FUTURE Founded in 1946, West-Ward Pharmaceuticals Corp. has a longstand- ing presence in the U.S. oral solid gener- ics market. The company is best known for its dedication to quality, reliability and customer service. West-Ward was purchased by Hikma Pharmaceuticals PLC in 1991. Serving as the U.S. operations arm of Hikma, West- Ward is responsible for marketing, plan- ning and distributing products in the injectable and noninjectable business units. Since becoming a wholly owned subsidiary of Hikma, West-Ward has grown and expanded considerably. As a result, the company has transformed itself into a world-class full-service generics manufacturer and supplier. Hikma/West-Ward is also committed to providing affordable branded medicines to consumers, including Mitigare ® (colchicine) 0.6 mg capsules. Some notable moments in West- Ward's recent history include: 2011: West-Ward acquires Baxter's high- volume, generic Multi-Source Injectables Division. 2014: Hikma/West-Ward further strengthens its position by acquiring select assets of Bedford Laboratories, Inc., the generic sterile injectables divi- sion of Boehringer Ingelheim. 2016: Hikma Pharmaceuticals PLC, West-Ward's parent company, purchas- es Roxane Laboratories Inc. and Boehringer Ingelheim Roxane Inc. (collectively "Roxane") from Boehringer Ingelheim Corporation, an established U.S. specialty generics company with a highly differentiated product portfolio and impressive research and development capabilities. The transaction brings together two important players in the generic phar- maceutical market. It also elevates West-Ward's position in the U.S. gener- ic market by revenue and expands its already extensive product line. Said Darwazah, Chairman and Chief Executive Officer of Hikma, had this to say about the acquisition of Roxane (now known as West-Ward Columbus): "We made significant strategic progress in 2016. The acquisition of West-Ward Columbus is transforming our generics business and the Group as a whole. This is our largest acquisition to date and the integration process has been both chal- lenging and exciting. We expect the generics business to achieve significant growth in revenue and profitability in the coming years as we focus on pipeline execution and portfolio opti- mization. "Our global injectables business delivered excellent growth in revenue and operating profit in 2016, at the same time as we doubled our research and development investment to underpin the long-term growth potential for this busi- ness. In the Middle East and North Africa, our reported results were impact- ed by the devaluation of the Egyptian pound in November 2016. However, our strategic focus on high- er-value products, combined with tight cost control, drove sig- nificant growth in operating profit in con- stant currency and a meaningful margin expansion. "Our business today is stronger than ever. We are well positioned across our markets, with a large and differentiated portfolio and pipeline and we are confi- dent in the future prospects of the Group." West-Ward is supported by seven FDA-approved manufacturing facilities around the world (three located state- side). The company credits its success to a commitment to providing cus- tomers the best possible service and high-quality pharmaceuticals. With the added financial strength of the parent company, Hikma Pharmaceuticals PLD, West-Ward has a solid foundation and a bright future. For more information, visit booth #601, go to www.west-ward.com or call 732.542.1191. THE CAMBER ADVANTAGE Camber's parent company, Hetero Drugs, began its journey as an API man- ufacturer, and today has expanded to all stages of pharmaceutical manufacturing, including novel research and commer- cial sales. Hetero has concentrated on key products where new approaches to synthesis and large scale production continue to bring significant value to the global market. The company's commitment to reli- ability, quality and value is unrivaled and has been at the heart of its operations since its inception in 1993. By leveraging its vertically integrated regime, Hetero offers a unique value proposition to cus- tomers by inspiring quality and cost effi- ciencies across the entire manufacturing process. Few companies compare to Hetero's expertise in process research and chemistry, API manufacturing, for- mulation development and manufactur- ing. With more than 300 Drug Master Files across most therapeutic cate- gories and emergence as a world leader in the production of anti-retroviral drugs for the treatment of HIV/AIDS, Hetero is truly a force in the global pharmaceutical industry. With the dedication and support of more than 15,000 employees globally, Hetero has been able to provide access to high quality, innovative medicines to patients in more than 120 countries and has significantly impacted human health throughout the world. However, beyond its size, scope of products, global foot- print and financial sta- bility, Hetero has built its reputation as a strong business partner on three fundamental attributes, being: reli- able, capable and value-driven. Hetero's reputation has attracted the most experi- enced and dedicated project managers, facilitating best-in-class customer/plant communications for transfers and pro- duction. With an integrated quality system to ensure adherence to cGMP practices, Hetero is committed to quality and its manufacturing facilities are approved by global regulatory agencies. In addition, Hetero continues to invest in adoption of advanced machinery, technologies and capabilities to ensure that it inspires high- est level of quality stan- dards. With more than 25 manufacturing facilities across the globe, includ- ing five plants in Special Economic Zones, Hetero can effortlessly scale up to meet product demands of both APIs and Formulations in large quantities. Hetero operates one of the world's largest Special Economic Zone complexes with more than 1,200 reactors dedicated for manufacturing APIs. At Camber and Hetero, the main objective is to leverage expertise across the pharma- ceutical value chain to deliver cost-effec- tive solutions for partners. For more information, go to www .camberpharma.com, call 732.529.0430 or visit booths #1510 and #1511.